Drug reference

romosozumab-aqqg

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1178, 1179

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(roe′moe-soz′ue-mab) Evenity

PDF page 1178

Functional class

Func. class.: Osteoporosis agent, sclerostin inhibitor

PDF page 1178

Uses

USES: Treatment of osteoporosis in postmenopausal females at high risk for fracture or those who have failed or are intolerant to other available osteoporosis therapy

PDF page 1179

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity, uncorrected hypocalcemia

PDF page 1179

Warnings and precautions

Black Box Warning: MI, stroke

PDF page 1179

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Osteoporosis in postmenopausal women at high risk for fracture Adult female SUBCUT 210 mg monthly × 12 mo

PDF page 1179

Available forms

Available forms: Injection 105 mg/1.17 mL, 210 mg/ 2.34 mL single-use prefilled syringe

PDF page 1179

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

romosozumab-aqqg

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1178, 1179

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(roe′moe-soz′ue-mab) Evenity

PDF page 1178

Functional class

Func. class.: Osteoporosis agent, sclerostin inhibitor

PDF page 1178

Uses

USES: Treatment of osteoporosis in postmenopausal females at high risk for fracture or those who have failed or are intolerant to other available osteoporosis therapy

PDF page 1179

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity, uncorrected hypocalcemia

PDF page 1179

Warnings and precautions

Black Box Warning: MI, stroke

PDF page 1179

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Osteoporosis in postmenopausal women at high risk for fracture Adult female SUBCUT 210 mg monthly × 12 mo

PDF page 1179

Available forms

Available forms: Injection 105 mg/1.17 mL, 210 mg/ 2.34 mL single-use prefilled syringe

PDF page 1179

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.